Neogen Chemicals · NSE: NEOGEN · BSE: 542665
Q4 FY26 results · Jan–Mar 2026
Neogen Chemicals reported revenue from operations of ₹246.56 crore (up 21.6% from Q4 FY25) and net profit of ₹11.39 crore (up 372.6% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 246.56 | 202.82 | +21.6% | 220.02 | +12.1% |
| Other income | 0.98 | 0.59 | +66.1% | 2.09 | −53.1% |
| Total income | 247.54 | 203.41 | +21.7% | 222.11 | +11.4% |
| Profit before tax | 15.85 | 3.63 | +336.6% | 5.65 | +180.5% |
| Net profit for the period | 11.39 | 2.41 | +372.6% | 3.69 | +208.7% |
| EPS, basic (₹) | 4.32 | 0.91 | +374.7% | 1.40 | +208.6% |
| Net margin (%) | 4.6 | 1.2 | 1.7 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 248.63 | 203.75 | +22.0% | 215.60 | +15.3% |
| Other income | 3.87 | 2.65 | +46.0% | 4.26 | −9.2% |
| Total income | 252.50 | 206.40 | +22.3% | 219.86 | +14.8% |
| Profit before tax | 19.92 | 7.75 | +157.0% | 11.80 | +68.8% |
| Net profit for the period | 14.66 | 5.19 | +182.5% | 8.77 | +67.2% |
| EPS, basic (₹) | 5.56 | 1.97 | +182.2% | 3.32 | +67.5% |
| Net margin (%) | 5.9 | 2.5 | 4.1 |
Consolidated
- Filed with BSE
- 16 May 2026, 23:10 IST
- Board meeting
- 16 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 16 May 2026, 23:10 IST
- Board meeting
- 16 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE